Apr 7, 2020 12:44 AM
BACK TO TOP
KSE100
30,579.15
-1042.64
(-3.30%)
ALLSHR
22,022.22
-493.37
(-2.19%)
KSE30
13,526.01
-488.74
(-3.49%)
KMI30
48,022.16
-1700.37
(-3.42%)
BKTi
10,469.41
-386.11
(-3.56%)
OGTi
11,191.63
-48.50
(-0.43%)
KMIALLSHR
14,589.99
-415.01
(-2.77%)
UPP9
9,471.92
-397.42
(-4.03%)
NITPGI
7,134.15
-218.18
(-2.97%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.164.19
-7.29
(-4.25%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Apr 6, 2020 3:35 PM
REG
FUT
ODL
Open
170.01
High
170.01
Low
163.01
Volume
64,300
CIRCUIT BREAKER
158.62 — 184.34
DAY RANGE
163.01 — 170.01
52-WEEK RANGE
81.55 — 193.00
Ask Price
164.19
Ask Volume
500
Bid Price
0.00
Bid Volume
0
LDCP
171.48
VAR
11.00
HAIRCUT
31.50
P/E Ratio (TTM)
17.19
1-Year Change *
16.80%
YTD Change *
2.25%
Open
173.00
High
173.00
Low
167.00
Close
167.00
Change
-2.61%
LDCP
171.48
Volume
56
Total Trades
11
CIRCUIT BREAKER
154.33 — 188.63
DAY RANGE
167.00 — 173.00
Ask Price
169.00
Ask Volume
1
Bid Price
165.01
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

KEY PEOPLE
Mr.Dmytro OliinykChairman
Ms. Erum Shakir RahimCEO
Mr. Syed Azeem Abbas NaqviCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.gsk.com.pk

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Deloitte Yousuf Adil & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
52,289,142.37
Shares
318,467,278
Free Float
51,732,159
Free Float
16.24%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 11, 2020financial Results for the Year Ended December 31, 2019 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended September 30, 2019 View   PDF
Oct 28, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Aug 29, 2019Transmission of Quarterly Report for the Period Ended June 30, 2019 View   PDF
Aug 28, 2019Financial Results for the Half Year Ended June 30, 2019 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended March 31, 2019 View   PDF
Apr 24, 2019Financial Results for the quarter ended March 31, 2019 View   PDF
Apr 3, 2019Transmission of Annual Report for the year ended 2018-12-31 View   PDF
Mar 4, 2019Financial Results for the Year Ended December 31, 2018 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 30 September 2018 View   PDF
DateTitleDocument
Mar 11, 2020Board Meeting - Number of Directors View   PDF
Mar 4, 2020Board of Directors Meeting GSK Pakistan Limited View   PDF
Feb 19, 2020Emergent Board Meeting View   PDF
Oct 21, 2019Board Meeting View   PDF
Aug 21, 2019Board of Directors Meeting View   PDF
Jun 19, 2019Board Meeting Other Than Financial Results View   PDF
Jun 12, 2019GSK Pakistan Limited - Board of Directors Meeting - Other Than Financial Results View   PDF
Apr 17, 2019Board of Directors Meeting View   PDF
Apr 3, 2019Notice of Annual General Meeting View   PDF
Feb 25, 2019Board of Directors Meeting - GlaxoSmithKline Pakistan Limited View   PDF
DateTitleDocument
Apr 2, 2020Change of Non-Executive Director View   PDF
Mar 26, 2020GLAXO | GlaxoSmithKline Pakistan Limited -Notice of Postponement of AGM PDF
Mar 2, 2020Change of Chief Executive/Director View   PDF
Feb 20, 2020Material Information - GlaxoSmithKline Pakistan Limited View   PDF
Feb 20, 2020Material Information - GSK Pakistan Limited View   PDF
Nov 15, 2019Corporate Briefing Session - GSK Pakistan Limited View   PDF
Oct 28, 2019Appointment of Chairman View   PDF
Sep 26, 2019Material Information View   PDF
Aug 28, 2019Change of Board Director of GSK Pakistan Limited View   PDF
May 15, 2019Notice of Credit of Final Cash Dividend in Newspapers View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales36,581,74934,006,84032,773,77027,563,533
Profit after Taxation3,041,1233,257,9512,981,0232,762,185
EPS9.5510.239.368.68
Q3 2019Q2 2019Q1 2019
Sales8,171,4409,285,4248,368,051
Profit after Taxation923,761341,678532,910
EPS2.901.071.67
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)21.0824.7426.4827.08
Net Profit Margin (%)8.319.589.1010.02
EPS Growth (%)(6.65)9.297.834.58
PEG(2.53)1.192.295.87

Payouts

DateFinancial ResultsDetailsBook Closure
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 22/04/2020 - 28/04/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 18, 2013 2:37 PM31/12/2012(YR) 40% (F) (D) - 10% (B) 12/04/2013 - 18/04/2013

Financial Reports